We're delighted to share our seventh annual #readinglist. For 2024, a time of rapid and dramatic change, we're focusing on classics and instant classics: five core curriculum books our leaders use to guide their long-term thinking and stay on track. Happy reading! https://bit.ly/3T4YJsS
Danaher Corporation
Herstellung medizinischer Geräte
Washington, District of Columbia 350,704 followers
Über uns
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
- Website
-
http://www.danaher.com
External link for Danaher Corporation
- Industrie
- Herstellung medizinischer Geräte
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Hauptsitz
- Washington, District of Columbia
- Typ
- Öffentliches Unternehmen
- Spezialitäten
- Life Sciences, Diagnostics, and Biotechnology
Standorte
-
Primäre
Wegbeschreibung erhalten
2200 Pennsylvania Ave NW
800 W
Washington, District of Columbia 20037, US
Employees at Danaher Corporation
Aktualisierungen
-
#AI has made an impact on digital pathology. Now, how can we effectively accelerate #digitalpathology workflows to maximize their impact and enhance patient care? https://lnkd.in/ewjADKni
-
-
Cytiva synthesizes findings from 800+ pharma and biopharma executives across 18 countries in their new Global #Biopharma #Sustainability Review. TL;DR: Companies with a proven commitment to sustainability see benefits in revenue, profit, share price, brand reputation and talent attraction. https://bit.ly/3XcHRmt
Making strides in sustainability is challenging. We surveyed 800 pharma and biopharma executives across 18 countries to learn more about the state of sustainability in biopharma. The Sustainability Review covers the industry’s sustainability progress in improving sustainability and the impact of prioritizing environmental initiatives. Dive into some of the findings here: https://cytiva.link/7fnal.
-
Danaher Corporation reposted this
𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁 We are proud to announce Genedata has joined Danaher Corporation, a leading global life sciences and diagnostics innovator. Over the past several years, Genedata and Danaher have engaged in several successful collaborations. Now, as a Danaher operating company, we expect to add to their broad workflow solutions that help accelerate drug discovery, development and manufacturing for critical new therapies. #speedoflife https://buff.ly/3MegMcl #Genedata #DanaherCorporation #LifeSciences #Innovation #Biopharma #DigitalizingBiopharma #GenedataDriven
-
-
We’re excited to share that Genedata, a leading provider of software solutions that digitalize and automate complex biopharma R&D processes, is joining Danaher. As a part of the Danaher Life Sciences segment, Genedata will further our efforts to accelerate the speed of drug discovery, development and manufacturing for critical new therapies. https://lnkd.in/eCdnii48
-
-
As a leading global life sciences and diagnostics innovator, Danaher is helping solve health challenges impacting patients around the world. https://bit.ly/4cr7AvQ
-
-
Excited to see this collaboration between Danaher Life Sciences businesses Molecular Devices and IDBS. QPix Insights, an #AI-powered software application, aims to transform the future of microbial research by accelerating project timelines, enhancing productivity and helping researchers achieve faster discoveries to drive innovations. #speedoflife 💜 https://lnkd.in/g26yG-b6
Introducing the all-new QPix Insights: Empowering Discovery, One Colony at a Time. Accelerate your research timelines, enhance the efficiency of your workflows, and drive groundbreaking discoveries with QPix Insights, our latest innovation in microbial screening and colony selection. Developed collaboratively by Molecular Devices and IDBS, QPix Insights is designed to revolutionize your research workflow by providing: ✅ User-Friendly Interface: Simplifies complex data analysis for all levels of scientific personnel. ✅ AI-Powered Precision: Reduces errors and increases data reliability. ✅ Streamlined Data Integration: Integrates data from various sources for a comprehensive overview. ✅ Cost and Time Savings: Identifies the right colony faster, reducing reruns and waste. ✅ Optimized Colony Selection: Recommends the best selection criteria to improve efficiency and quality. Why QPix Insights? It accelerates project timelines, enhances productivity by allowing you to focus on critical research, and helps you achieve faster discoveries to drive innovations. Join us in transforming the future of microbial research! Visit our website to learn more and schedule a demo: https://bit.ly/46xHcim #Biotech #Innovation #Biotech
-
How can #AI enable faster adoption of digital pathology? Discover how Danaher is helping clinicians seek answers to the diagnostic questions that matter most for patient care. https://bit.ly/4dTjq39
-
-
“With rapid genes, customers can expect faster turnaround times, consistent pricing and a trusted partner that can deliver a complete solution to advance their drug discovery work sooner,” said Integrated DNA Technologies' Sandy Ottensmann. Proud to see #IDT innovating at the #speedoflife 💜
Fast genes are in our DNA! 🧬 We are delighted to officially launch our rapid genes—available in 125-2000 base pairs, these ready-to-use genes are #NGS-verified and are shipped in as little as five business days so that your research doesn’t have to wait. Read more here: https://idtb.io/dhj72v #rapidgenes #synbio #syntheticbiology
-
ICYMI, our beloved collaborator Fyodor Urnov of the Innovative Genomics Institute has been on a tour of Danaher operating companies. We're delighted to hear that during his most recent stop at Aldevron, he gave a talk about how our partnership aims to take gene-editing therapies "from N=rare to N=all." We're right there with you, Fyodor!
The power of collaboration was evident today as we welcomed Dr. Fyodor Urnov from the Innovative Genomics Institute to Aldevron’s Madison, WI, site. #TeamAldevron staffed facility tour stops as Dr. Urnov and colleagues from Danaher Corporation and Integrated DNA Technologies, learned more about our work and our facility. The highlight was Dr. Urnov’s “Lunch and Learn” presentation “The Danaher-IGI Beacon for CRISPR Cures: From N=rare to N=all," to our on-site associates, and those tuning in around the globe. His enthusiasm for our work and the potential for the Danaher-IGI Beacon for CRISPR Cures, launched earlier this year, was unmistakable. “We have the right leadership with the right vision. I solute IDT and Aldevron for their corporate culture that is committed to innovate.” #CRISPR Tom Foti Anu Codaty Rolf Turk Sandy Ottensmann Jennifer Moody Sadik Kassim #inthenews
-
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Aktie
DHR
NYSE
20 Minuten Verzögerung
$266.06
-2.76 (-1.027%)
- Öffnen Sie
- 268.03
- Niedrig
- 265.21
- Hoch
- 268.97
Daten von Refinitiv
Siehe mehr Informationen auf